The discussions reflect a balanced curiosity and cautious interpretation of the research, with posts mentioning phrases like 'surprisingly' and 'we can learn from this' to express interest and tentative agreement. The tone remains mostly informative and respectful, highlighting the article's relevance without overly emotional language, which indicates a moderate but meaningful engagement on the topic.
AgreementModerate agreement
Most discussions show alignment with the idea that well-controlled asthma may not significantly increase COVID-19 severity, though some acknowledge potential risks for severe or uncontrolled asthma.
InterestModerate interest
The posts demonstrate moderate interest, with many referencing the publication and emphasizing its relevance to current health concerns without deep technical dives.
EngagementModerate engagement
Participants show some engagement by referencing the article and sharing opinions, but few delve into detailed analysis or methodology, indicating a moderate level of depth.
ImpactModerate impact
The discussions suggest the publication influences how people consider asthma's role in COVID-19 outcomes, especially in public health contexts, reflecting moderate impact.
Abstract in brief
Asthma is being studied to determine if it increases the risk of severe outcomes from COVID-19, such as hospitalization or ICU admission.
Current research suggests that well-controlled asthma may not significantly raise the risk, but severe or uncontrolled asthma could potentially lead to worse COVID-19 outcomes.
It's important for asthma patients to manage their condition properly and follow public health guidelines to reduce their risk.]
Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Corresponding Author: Sebastian Johnston; Download Article Here: https://t.co/Z8avoUYBzj #asthma #COVID19 #COVID #Corona
https://t.co/b9CsnEx6pJ https://t.co/3QAhvlo5GJ
May 5, 2020 · 9 likes · 15 shares · 6,007 followersView post →
AE
Allergy EAACI
@AllergyEaaci · X
Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-19 Virtual Issue: https://t.co/f7dRWpQh46, https://t.co/DHoGafww9v, https://t.co/HwQOZVTedF, https://t.co/TuF0AzYS74, https://t.co/BTJFAWEwzU https://t.co/I7UsMgvxTs
May 16, 2020 · 7 likes · 10 shares · 6,007 followersView post →
AE
Allergy EAACI
@AllergyEaaci · X
Free Access: Asthma and COVID‐19: Is asthma a risk factor for severe outcomes? First and corresponding author: Sebastian L. Johnston. First published: 02 May 2020. Download Article Here: https://t.co/Z8avoUYBzj
Dec 28, 2020 · 1 like · 6,007 followersView post →
T
Tassos
@tg128 · X
@ketelapongo Διάβασε αυτό https://t.co/nYLqTzx7mJ και φτάσε στο surprisingly. Θα δεις ότι δεν είναι τόσο σοβαρό πρόβλημα
Sep 8, 2020 · 1 like · 2 shares · 4,638 followersView post →
JM
Juan C Ivancevich MD
@Aller_MD · X
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 7,482 followersView post →
AE
Allergy EAACI
@AllergyEaaci · X
Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic?
https://t.co/sD3EoyXLmd
Asthma and COVID‐19: is asthma a risk factor for severe outcomes?
https://t.co/xeNUhs66cs
Aug 13, 2020 · 1 share · 6,007 followersView post →
I recently recovered from COVID-19, which was likely contracted in a professional setting and transmitted to my family. This series discusses my clinical case, focusing on protective measures, early-phase treatment…
I recently recovered from COVID-19, which appears to have impacted my professional environment as a doctor and my family. This series discusses my clinical case in detail, focusing on protective measures, potential…
I recently recovered from COVID-19, which was likely contracted at work and transmitted to my family. This series discusses my clinical case, focusing on protective measures, medications, symptoms, risk monitoring, and…
I recently recovered from COVID-19, which impacted my professional life significantly. This video discusses my clinical case, focusing on protective measures, early symptoms, risk factors, monitoring, and the treatment…
Free Access: Asthma and COVID‐19: Is asthma a risk factor for severe outcomes? First and corresponding author: Sebastian L. Johnston. First published: 02 May 2020. Download Article Here: https://t.co/Z8avoUYBzj
Dec 28, 2020 · 1 like · 6,007 followersView post →
HX
Helen Xenikaki
@taxidiwtis · X
RT @tg128: @ketelapongo Διάβασε αυτό https://t.co/nYLqTzx7mJ και φτάσε στο surprisingly. Θα δεις ότι δεν είναι τόσο σοβαρό πρόβλημα
@ketelapongo Διάβασε αυτό https://t.co/nYLqTzx7mJ και φτάσε στο surprisingly. Θα δεις ότι δεν είναι τόσο σοβαρό πρόβλημα
Sep 8, 2020 · 1 like · 2 shares · 4,638 followersView post →
AE
Allergy EAACI
@AllergyEaaci · X
Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic?
https://t.co/sD3EoyXLmd
Asthma and COVID‐19: is asthma a risk factor for severe outcomes?
https://t.co/xeNUhs66cs
Aug 13, 2020 · 1 share · 6,007 followersView post →
HM
Heidi Makrinioti
@HMakrinioti · X
too many experts in COVID-19 - too many...we can definitely learn from someone who has spent his life exploring and defining the mechanisms behind virus-induced exacerbations of asthma with an emphasis in the last paragraph https://t.co/w7UWS34UAO
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 1,771 followersView post →
A
ARIAguideline
@ARIAGuideline · X
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 2,355 followersView post →
FL
Fundación Libra
@FUNDACIONLIBRA · X
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 414 followersView post →
I
Interasma
@Interasma · X
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 2,447 followersView post →
JM
Juan C Ivancevich MD
@Aller_MD · X
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 7,482 followersView post →
EJ
EAACI JM
@EAACI_JM · X
RT @AllergyEaaci: Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-…
May 16, 2020 · 10 shares · 3,964 followersView post →
AE
Allergy EAACI
@AllergyEaaci · X
Allergy’s Virtual Issue on COVID-19: https://t.co/76bcW5NIvN
Five recently accepted papers have been added to our COVID-19 Virtual Issue: https://t.co/f7dRWpQh46, https://t.co/DHoGafww9v, https://t.co/HwQOZVTedF, https://t.co/TuF0AzYS74, https://t.co/BTJFAWEwzU https://t.co/I7UsMgvxTs
May 16, 2020 · 7 likes · 10 shares · 6,007 followersView post →
KN
Katja Nemat
@ddkinderallergo · X
#Asthma and #COVID‐19: is asthma a risk factor for severe outcomes? https://t.co/m5EgxtZVks
RT @AllergyEaaci: Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Corresponding Author: Sebastian Johnston; Download Arti…
May 5, 2020 · 15 shares · 278 followersView post →
MV
Marylín Valentin
@marylinvalenti5 · X
RT @AllergyEaaci: Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Corresponding Author: Sebastian Johnston; Download Arti…
May 5, 2020 · 15 shares · 4,547 followersView post →
AE
Allergy EAACI
@AllergyEaaci · X
Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Corresponding Author: Sebastian Johnston; Download Article Here: https://t.co/Z8avoUYBzj #asthma #COVID19 #COVID #Corona
https://t.co/b9CsnEx6pJ https://t.co/3QAhvlo5GJ
May 5, 2020 · 9 likes · 15 shares · 6,007 followersView post →
B
Publications | Faculty of Medicine | Imperial College London
https://doi.org/10.1111/all.14348; Makris, S., Paulsen, M., & Johansson, C. (2017). Type I Interferons as Regulators of Lung Inflammation. Frontiers in ...
IRAS 14348-1447, an Ultraluminous Pair of Colliding, Gas-Rich ...
News
https://doi.org/10.1111/j.1365-2966.2009.15306.x · Crossref. J. D. Younger ... All News · ScienceInsider · News Features · Subscribe to News from Science · News ...
Blockade of Acetylcholine Receptors: A Model of Myasthenia Gravis ...
News
https://doi.org/10.1111/nmo.14348 · Crossref. Jaap J. Plomp,; Maartje G.M. ... All rights reserved. AAAS is a partner of HINARI, AGORA, OARE, CHORUS ...